Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
It is a triple agonist that simultaneously activates three different receptor systems: GLP-1, GIP, and glucagon
GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses
.webp)
Abbasinejad, MD , reviews each patients BMI, medical history, weight loss goals, and previous efforts before recommending an appropriate option
Type 1 diabetes: Retatrutide is not indicated for type 1 diabetes and should not be used as a substitute for insulin
US$ 21.35
US$ 28.73
US$ 20.60
